The enteric serotonergic system is altered in patients with diverticular disease

Gut

Volumn 62, Issue 12, 2013, Pages 1753-1762

  Böttner, Martina ^a   Barrenschee, Martina ^a   Hellwig, Ines ^a   Harde, Jonas ^a   Egberts, Jan Hendrik ^b   Becker, Thomas ^b   Zorenkov, Dimitri ^b   Wedel, Thilo ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN TRANSPORTER; SMOOTH MUSCLE ACTIN; TRYPTOPHAN HYDROXYLASE;

5HT 4R GENE; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; COLON DIVERTICULOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; M2R GENE; M3R GENE; MALE; MOTOR DYSFUNCTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SEROTONINERGIC SYSTEM; TISSUE DISTRIBUTION;

COLONIC DISEASES; ENTERIC NERVOUS SYSTEM; ENTERIC NEUROMUSCULAR DISEASE; REAL TIME PCR; SEROTONIN;

AGED; CASE-CONTROL STUDIES; COLON, SIGMOID; DIVERTICULUM, COLON; ENTERIC NERVOUS SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, SEROTONIN, 5-HT2; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SEROTONIN, 5-HT4; SEROTONERGIC NEURONS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSCRIPTOME; TRYPTOPHAN HYDROXYLASE;

EID: 84887476112     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-302660     Document Type: Article

References (43)

1. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000;95:2698-709.
2. Cote F, Thevenot E, Fligny C, et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A 2003;100:13525-30.
3. Galligan JJ, Parkman H. Recent advances in understanding the role of serotonin in gastrointestinal motility and functional bowel disorders. Neurogastroenterol Motil 2007;19(Suppl. 2):1-4.
4. Gershon MD. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;20(Suppl. 7):3-14.
5. Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 2007;50:376-88.
6. Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 2005;39(5Suppl. 3):S184-93.
7. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397-414.
8. Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs 2010;19:765-75.
9. Briejer MR, Prins NH, Schuurkes JA. Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs. Neurogastroenterol Motil 2001;13:465-72.
10. Priem E, Van Colen I, De Maeyer JH, et al. The facilitating effect of prucalopride on cholinergic neurotransmission in pig gastric circular muscle is regulated by phosphodiesterase 4. Neuropharmacology 2012;62:2126-35.
11. Quigley EM. Prucalopride: safety, efficacy and potential applications. Ther Adv Gastroenterol 2012;5:23-30.
12. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-11.
13. Simpson J, Scholefield JH, Spiller RC. Pathogenesis of colonic diverticula. Br J Surg 2002;89:546-54.
14. Simpson J, Sundler F, Humes DJ, et al. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009;21:847-e58.
15. Knowles CH, De Giorgio R, Kapur RP, et al. The London classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut 2010;59:882-7.
16. Painter NS, Truelove SC, Ardran GM, et al. Effect of morphine, prostigmine, pethidine, and probanthine on the human colon in diverticulosis studied by intraluminal pressure recording and cineradiography. Gut 1965;6:57-63.
17. Parks TG, Connell AM. Motility studies in diverticular disease of the colon. Gut 1969;10:534-42.
18. Golder M, Burleigh DE, Belai A, et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003;361:1945-51.
19. Wedel T, Busing V, Heinrichs G, et al. Diverticular disease is associated with an enteric neuropathy as revealed by morphometric analysis. Neurogastroenterol Motil 2010;22:407-14; e93-4.
20. Deduchovas O, Saladzinskas Z, Tamelis A, et al. Morphologic pattern of myenteric neural plexus in colonic diverticular disease. A whole-mount study employing histochemical staining for acetylcholinesterase. Ann Anat 2008;190:525-30.
21. Banerjee S, Akbar N, Moorhead J, et al. Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition. Int J Colorectal Dis 2007;22:643-9.
22. Costedio MM, Coates MD, Danielson AB, et al. Serotonin signaling in diverticular disease. J Gastrointest Surg 2008;12:1439-45.
23. Böttner M, Bar F, Von Koschitzky H, et al. Laser microdissection as a new tool to investigate site-specific gene expression in enteric ganglia of the human intestine. Neurogastroenterol Motil 2010;22:168-72; e52.
24. Whiteway J, Morson BC. Elastosis in diverticular disease of the sigmoid colon. Gut 1985;26:258-66.
25. Mimura T, Bateman AC, Lee RL, et al. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease. Dis Colon Rectum 2004;47:371-8; discussion 8-9.
26. Stumpf M, Cao W, Klinge U, et al. Increased distribution of collagen type III and reduced expression of matrix metalloproteinase 1 in patients with diverticular disease. Int J Colorectal Dis 2001;16:271-5.
27. Liu M, Geddis MS, Wen Y, et al. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2005;289:G1148-63.
28. Sakurai-Yamashita Y, Yamashita K, Kanematsu T, et al. Localization of the 5-HT (4) receptor in the human and the guinea pig colon. Eur J Pharmacol 1999;383:281-5.
29. Kilbinger H, Wolf D. Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1992;345:270-5.
30. Liu MT, Kuan YH, Wang J, et al. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 2009;29:9683-99.
31. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998;115:370-80.
32. Briejer MR, Bosmans JP, Van Daele P, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 2001;423:71-83.
33. Kuemmerle JF, Murthy KS, Grider JR, et al. Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology 1995;109:1791-800.
34. Tam FS, Hillier K, Bunce KT. Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol 1994;113:143-50.
35. Hoffman JM, Tyler K, MacEachern SJ, et al. Activation of colonic mucosal 5-HT (4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 2012;142:844-54 e4.
36. Kirchgessner AL, Tamir H, Gershon MD. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci 1992;12:235-48.
37. Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 2000;20:3295-309.
38. Sidhu M, Cooke HJ. Role for 5-HT and ACh in submucosal reflexes mediating colonic secretion. Am J Physiol 1995;269:G346-51.
39. Linden DR, Chen JX, Gershon MD, et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003;285:G207-16.
40. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-64.
41. Tutton PJ. The influence of serotonin on crypt cell proliferation in the jejunum of rat. Virchows Arch B Cell Pathol 1974;16:79-87.
42. Gill RK, Saksena S, Tyagi S, et al. Serotonin inhibits Na+/H+ exchange activity via 5-HT4 receptors and activation of PKC alpha in human intestinal epithelial cells. Gastroenterology 2005;128:962-74.
43. Baxter GS, Craig DA, Clarke DE. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol 1991;343:439-46.